PRHC
BMY icon

P.R. Herzig & Co’s Bristol-Myers Squibb BMY Stock Holding History

P.R. Herzig & Co’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		– Sell
-27,550
Closed -$1.52M – 8
2018
Q2 		$1.52M Buy
27,550
+801
+3% +$43.3K 3.32% 13
2018
Q1 		$1.69M Sell
26,749
-6,899
-21% -$444K 3.4% 11
2017
Q4 		$2.06M Buy
33,648
+1
+0% +$63 3.96% 8
2017
Q3 		$2.15M Buy
33,647
+2
+0% +$117 4.15% 5
2017
Q2 		$1.88M Buy
33,645
+1,301
+4% +$70.8K 3.63% 9
2017
Q1 		$1.76M Buy
32,344
+8,451
+35% +$464K 3.42% 10
2016
Q4 		$1.4M Buy
23,893
+18,852
+374% +$1.03M 2.85% 15
2016
Q3 		$272K Buy
5,041
+600
+14% +$38.5K 0.53% 50
2016
Q2 		$327K Sell
4,441
-1,099
-20% -$77.7K 0.69% 43
2016
Q1 		$354K Sell
5,540
-1,199
-18% -$75.6K 0.78% 38
2015
Q4 		$464K Buy
6,739
+1
+0% +$66 1.12% 33
2015
Q3 		$399K Sell
6,738
-2,899
-30% -$184K 1% 34
2015
Q2 		$641K Sell
9,637
-2,799
-23% -$184K 1.3% 33
2015
Q1 		$802K Sell
12,436
-699
-5% -$43.8K 1.37% 28
2014
Q4 		$775K Buy
13,135
+1
+0% +$56 1.2% 36
2014
Q3 		$672K Sell
13,134
-49
-0.4% -$2.45K 1% 40
2014
Q2 		$639K Buy
13,183
+1
+0% +$49 0.85% 41
2014
Q1 		$685K Sell
13,182
-2,531
-16% -$135K 0.9% 43
2013
Q4 		$835K Sell
15,713
-1,599
-9% -$81.5K 1.03% 39
2013
Q3 		$801K Buy
17,312
+6,154
+55% +$270K 1.04% 39
2013
Q2 		$499K Buy
+11,158
New +$484K 0.96% 30

Other funds holding BMY

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

P.R. Herzig & Co's BMY Position: Q3 2018 in Review

P.R. Herzig & Co sold out of Bristol-Myers Squibb (BMY) in Q3 2018, closing a stake of 27,550 shares — an estimated $1.52M sold.

P.R. Herzig & Co first reported a position in BMY in Q2 2013 and held it in 21 quarters. The position peaked at $2.15M in Q3 2017. 1,729 funds tracked by Wall St. Rank hold BMY as of Q3 2018.

  • P.R. Herzig & Co reported no remaining Bristol-Myers Squibb position as of Q3 2018 after selling out during the quarter.
  • P.R. Herzig & Co sold 27,550 Bristol-Myers Squibb shares in Q3 2018, an estimated $1.52M.
  • P.R. Herzig & Co first reported a position in Bristol-Myers Squibb in Q2 2013 and held it in 21 quarters.
  • P.R. Herzig & Co's Bristol-Myers Squibb position peaked at $2.15M in Q3 2017.
  • 1,729 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2018.

Based on P.R. Herzig & Co's 13F filing for Q3 2018.